Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial
Martedì 7 settembre 2021
circa 1 minuti di lettura
Journal and Affiliations:
European Heart Journal - Acute Cadiovascular Care, 7 settembre 2021
Antonio Landi, Cardiologia, Cardiocentro Ticino, EOC, Lugano
Giovanni Pedrazzini, Cardiologia, Cardiocentro Ticino, EOC, Lugano
Marco Valgimigli, Cardiologia, Cardiocentro Ticino, EOC, Lugano
Tags:
acute coronary syndromes
acute kidney injury
bivalirudin
unfractionated heparin
Authors:
Antonio Landi
Giovanni Pedrazzini
Marco Valgimigli